Recurrent Classical Hodgkin Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09035Nivolumab2Completed1
DB09037Pembrolizumab2Completed1
DB08877Ruxolitinib2Completed1